Page last updated: 2024-11-03

pyrimethamine and Cancer of Pituitary

pyrimethamine has been researched along with Cancer of Pituitary in 1 studies

Maloprim: contains above 2 cpds

Research Excerpts

ExcerptRelevanceReference
"Invasive pituitary adenomas (PAs) are generally refractory to conventional therapy and salvage treatment with temozolomide (TMZ)."1.39Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. ( Bao, X; Cai, F; Dai, C; Deng, K; Feng, M; Guo, K; Jiao, Y; Junji, W; Lian, W; Liu, X; Ma, S; Wang, R; Wei, Z; Xing, B; Yang, Y; Yao, Y; Zhang, B, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, C1
Zhang, B1
Liu, X1
Guo, K1
Ma, S1
Cai, F1
Yang, Y1
Yao, Y1
Feng, M1
Bao, X1
Deng, K1
Jiao, Y1
Wei, Z1
Junji, W1
Xing, B1
Lian, W1
Wang, R1

Other Studies

1 other study available for pyrimethamine and Cancer of Pituitary

ArticleYear
Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways.
    International journal of cancer, 2013, Oct-15, Volume: 133, Issue:8

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspas

2013